Xona Microfluidics, Inc.

Research Triangle Park, NC · Biotech · Private

Compartmentalized microfluidic chips for culturing human neurons in 3D to screen for tau mislocalization and identify Alzheimer's disease therapeutics

Claim this profile

Follows are private to you and power your alerts

Updated · xonamicrofluidics.com

Sector
Biotech
Headquarters
Research Triangle Park, NC
Total capital
$5.4M
Federal grants
$5.3M
9 awards · 2016–2023
Rank in peer group#14 of 18
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
$104K
3 awards · Veterans Affairs
Rank in Biotech#326 of 4373
Granted patents
0
5 pending

Capital timeline

20162017201820192020202120222023FEDERAL ↑EQUITY ↓Cumulative $5.4M$764K$2M$805K$339K$268K$535K
2016201820202022FEDERAL ↑EQUITY ↓Cumulative $5.4M$2M$805K$535K

Latest events

  • Federal contractVeterans Affairs · Xona Double Open$37K
  • Federal grantHealth and Human S · Phase I · Tau mislocalization assay to screen AD therapeutics using compartmentalized chips$267K
  • Federal grantHealth and Human S · Phase I · Tau mislocalization assay to screen AD therapeutics using compartmentalized chips$535K
  • Federal grantHealth and Human S · Phase I · Tau mislocalization assay to screen AD therapeutics using compartmentalized chips$268K
  • Federal contractVeterans Affairs · Laboratory Microfluidic Chambers$32K
  • Federal contractVeterans Affairs · 1 Rd SERIES(RD150/RD450/RD900)150UM,450UM, Or 900UM Microgroove Barrier. 2 Tcnd SERIES(TCND500,TCND1000)$36K
  • Federal grantHealth and Human S · Phase I · A user-friendly microfluidic chip for anti-epileptogenic drug screening$225K
Show 5 earlier federal awards
  • Federal grantHealth and Human S · Phase II · A user-friendly scalable microfluidic platform for enhanced neuron-cell culture$339K
  • Federal grantHealth and Human S · Phase II · A user-friendly scalable microfluidic platform for enhanced neuron-cell culture$85K
  • Federal grantHealth and Human S · Phase II · A user-friendly scalable microfluidic platform for enhanced neuron-cell culture$805K
  • Federal grantHealth and Human S · Phase II · A user-friendly scalable microfluidic platform for enhanced neuron-cell culture$2M
  • Federal grantHealth and Human S · Phase II · A user-friendly scalable microfluidic platform for enhanced neuron-cell culture$764K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 18 peers

Line = median

Biotech · Device

  • Federal grantsBelow median
  • Linked publications#1 · top 6%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 5
  • PendingApparatus And Method For Growing Neural Cells And Compartmentalizing Axons And DendritesUSPTOApplication 18226690
  • PendingApparatus And Method For Humidifying Cell CulturesUSPTOApplication 16829699
  • PendingApparatus And Method For Growing Neural Cells And Compartmentalizing Axons And DendritesUSPTOApplication 63528245
Show all 5 patent records
  • Apparatus And Method For Growing Neural Cells And Compartmentalizing Axons And DendritesFeb 1, 2024 · Application 18226690Pending
  • Apparatus And Method For Humidifying Cell CulturesOct 1, 2020 · Application 16829699Pending
  • Apparatus And Method For Growing Neural Cells And Compartmentalizing Axons And DendritesApplication 63528245Pending
  • Apparatus And Method For Growing Neural Cells And Compartmentalizing Axons And DendritesApplication 63526616Pending
  • Apparatus And Method For Humidifying Cell CulturesApplication PCTUS2020024660Pending

Recent research by its founders

  • Cloning SU8 silicon masters using epoxy resins to increase feature replicability and production for cell culture devices20202 cites
  • Distal axotomy enhances retrograde presynaptic excitability onto injured pyramidal neurons via trans-synaptic signaling20200 cites
  • Integration of pre-aligned liquid metal electrodes for neural stimulation within a user-friendly microfluidic platform20200 cites

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .